Cutera Inc. (NASDAQ:CUTR) shares traded down 3.6% on Tuesday . The company traded as low as $10.77 and last traded at $11.10, with a volume of 69,170 shares changing hands. The stock had previously closed at $11.52.

Separately, Zacks Investment Research lowered shares of Cutera from a “hold” rating to a “sell” rating in a report on Wednesday, May 4th.

The firm’s market capitalization is $145.29 million. The firm’s 50-day moving average price is $11.01 and its 200-day moving average price is $11.11.

Cutera (NASDAQ:CUTR) last released its earnings results on Monday, August 1st. The medical device company reported $0.07 EPS for the quarter, topping the Zacks’ consensus estimate of ($0.01) by $0.08. During the same period last year, the firm earned ($0.13) EPS. The firm had revenue of $27.50 million for the quarter, compared to analyst estimates of $26.20 million. The company’s revenue for the quarter was up 21.8% compared to the same quarter last year. On average, equities research analysts predict that Cutera Inc. will post ($0.02) EPS for the current year.

In other Cutera news, CEO Kevin P. Connors sold 21,606 shares of the business’s stock in a transaction that occurred on Tuesday, June 7th. The stock was sold at an average price of $10.29, for a total value of $222,325.74. Following the completion of the transaction, the chief executive officer now directly owns 657,484 shares of the company’s stock, valued at $6,765,510.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Kevin P. Connors sold 33,098 shares of the business’s stock in a transaction that occurred on Thursday, June 2nd. The shares were sold at an average price of $10.58, for a total value of $350,176.84. Following the completion of the transaction, the chief executive officer now directly owns 645,478 shares of the company’s stock, valued at $6,829,157.24. The disclosure for this sale can be found here.

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.